Immunotherapy combo shows promise against tough esophageal cancer
NCT ID NCT02998268
First seen Apr 20, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation can help people with locally advanced esophageal adenocarcinoma. About 42 adults whose cancer has not spread far but is too large for immediate surgery will receive the combination treatment. The main goal is to see if more tumors shrink or disappear completely after treatment, which may improve long-term survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
USC Keck School of Medicine, Norris Cancer Center
Los Angeles, California, 90033, United States
-
University of Michigan
Ann Arbor, Michigan, 48109-5848, United States
-
Weill Cornell Medicine
New York, New York, 10068, United States
Conditions
Explore the condition pages connected to this study.